approved EB-2 (NIW) RFE Issued

AI Engineer

Computer Science · China · 2025-10-31

Processing Time
145 days
Decision Date
2025-10-31
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue developing advanced AI models for medical information extraction and drug dosage prediction. This work focuses on automating clinical data analysis and enhancing personalized medicine through causal relation extraction and drug interaction prediction. The intended impact is to improve clinical efficiency, patient safety, and healthcare decision-making within the U.S. healthcare system.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor was shown to support critical national objectives in healthcare outcomes and cost reduction through AI automation.

2 Well-positioned to Advance the Endeavor Met

The petitioner's Ph.D., publication record, and 155 citations demonstrate her expertise and standing in the field of medical AI.

3 Waiver Benefit Met

On balance, the petitioner's unique combination of data science and biomedical expertise provides a benefit to the U.S. that outweighs the need for labor certification.

Why This Petition Was Approved

The petition was approved based on the petitioner's Ph.D. in Computer Science and her record of 4 publications (2 journal articles and 2 conference papers) which garnered 155 citations. Evidence also included her role as a peer reviewer for 6 journals/conferences and expert testimony confirming her impact on pharmaceuticals and public health. All three Dhanasar prongs were satisfied after a successful RFE response.

Request for Evidence (RFE)

Successfully Addressed

The RFE focused on the national importance of the work; the response provided evidence of alignment with national healthcare goals and the real-world relevance of the AI models.

RFE Targets
Substantial Merit and National Importance

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Independent
Judging Experience
Original Contributions
Government Alignment

Similar Cases

Data Analyst

Healthcare · China

WeGreened EB-2 (NIW) approved
New York 38 days 2025-05-31
The petitioner proposes to develop and implement advanced data analytics, machine learning models, and statistical methodologies to analyze healthcare operations and patient outcomes. Her work aims to inform evidence-based decision-making, enhance clinical workflows, and increase the overall quality of care across integrated healthcare systems.

Data Analyst

Healthcare · Iran

WeGreened EB-2 (NIW) approved
South Carolina 60 days 2025-01-29
The petitioner proposes to integrate artificial intelligence and advanced data science methodologies into clinical research to reshape drug development and clinical trial design. His work focuses on using AI models to automate clinical trial protocols, uncovering healthcare disparities through data science, and developing predictive tools for diagnostic accuracy. The goal is to reduce the high costs of drug development and improve patient outcomes in the U.S. healthcare system.

Others

Biotechnology · China

WeGreened EB-2 (NIW) approved
Connecticut 48 days 2025-05-12
The petitioner proposes to develop novel computational methods, integrating artificial intelligence and machine learning, to extract actionable insights from healthcare and electronic health records (EHR) data. The work focuses on optimizing physician workflows, improving healthcare provider productivity, and facilitating more accurate clinical decision-making to enhance patient outcomes.

Others

Biotechnology · China

WeGreened EB-2 (NIW) approved
Georgia 67 days 2025-05-14
The petitioner proposes to develop advanced artificial intelligence models and algorithms to improve early disease diagnosis and predict patient responses to new drugs and combination therapies. This work focuses on enhancing diagnostic precision and treatment effectiveness to accelerate drug discovery and optimize healthcare outcomes. The endeavor specifically aims to benefit vulnerable populations, including infants and the elderly, through optimized medical interventions.

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-10-31.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 145 days
RFE Issued
Criteria Met 3 / 3
Evidence Types 6

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,895
Success Rate 54.2%
Sustained 2,112
Dismissed 1,687

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist